RenovoRx Inc

General ticker "RNXT" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $32.0M

RenovoRx Inc does not follow the US Stock Market performance with the rate: -19.1%.

Estimated limits based on current volatility of 5.1%: low 1.15$, high 1.28$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.38$, 1.41$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.37$, 1.29$]

Financial Metrics affecting the RNXT estimates:

  • Negative: Non-GAAP EPS, $ of -1.16 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -57.21 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
  • Positive: Inventory ratio change, % of 0 <= 0
  • Negative: Industry operating profit margin (median), % of -98.30 <= 2.14

Similar symbols

Short-term RNXT quotes

Long-term RNXT plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $5.67MM $9.95MM $11.40MM
Operating Income $-5.67MM $-9.95MM $-11.40MM
Non-Operating Income $-0.65MM $0.04MM $1.16MM
Interest Expense $0.83MM $0.06MM $0.11MM
R&D Expense $3.04MM $4.30MM $5.67MM
Income(Loss) $-6.32MM $-9.91MM $-10.23MM
Profit(Loss) $-6.32MM $-9.91MM $-10.23MM
Stockholders Equity $15.35MM $6.16MM $-3.00MM
Assets $16.29MM $7.26MM $1.47MM
Operating Cash Flow $-5.92MM $-8.81MM $-10.26MM
Capital expenditure $0.01MM $0.00MM $0.00MM
Investing Cash Flow $-0.01MM $-2.03MM $2.03MM
Financing Cash Flow $19.33MM $0.04MM $5.01MM
Earnings Per Share* $-0.79 $-1.08 $-0.99

* EPS are Split Adjusted, recent splits may be reflected with a delay.